About this trial
Aim: The main goal of this observational study is to determine the prevalence of Human Papilloma Virus(HPV) infection, and Hepatitis B (Hep B) immunity amongst women of childbearing age 13 to 45 years) attending clinics at Mtshabezi Mission and Matobo clinic respectively; and assess behavioral risk factors of high school students at these catchment areas that can put them at risk for developing cancer of the cervix and liver.
Question: Can screening for cancer, and vaccination against Hep B and HPV, and cognitive behavior intervention help in preventing related cancers amongst these groups of participants.
Eligibility criteria
Qualifiers
None
Disqualifiers
males who are not enrolled in these participating High Schools.
children below the age of thirteen who are not enrolled in high schools and are not seeking prenatal, post-partum and family planning services at these selected health facilities during the project period.
Any eligible potential participant without a valid consent.
Any potential participant who is excluded by a doctor or midwife for a known contraindicating medical condition that can lead to potential harm to the participant or staff.
Trial design
Treatments tested in this trial
- Gardasil 9 vaccine
- Hepatitis B Virus Vaccine(HBV)
- Cognitive Behavioral Therapy
Treatment groups
Locations
Sponsors and collaborators
Eunice Dube
Lead sponsor
National University of Science and Technology, Zimbabwe
Collaborator